Safety and efficacy of galantamine (Reminyl) in severe Alzheimer's disease (the SERAD study): a randomised, placebo-controlled, double-blind trial - Concepedia

Concepedia

Publication | Closed Access

Safety and efficacy of galantamine (Reminyl) in severe Alzheimer's disease (the SERAD study): a randomised, placebo-controlled, double-blind trial

150

Citations

24

References

2008

Year

Alistair Burns, Roberto Bernabei, Roger Bullock, Alfonso J. Cruz‐Jentoft, Lutz Frölich, Christoph Höck, Minna Raivio, Eric Triau, M. Vandewoude, Anders Wimo,

The Lancet Neurology

Neurodegenerative DiseasesSevere AlzheimerAlzheimer's DiseaseMedicineDouble-blind TrialVascular DementiaNeuropharmacologySerad StudyNeurologyAging-associated DiseaseNeurodegenerationPharmacologyTreatment

References

	Year	Citations

Page 1

Page 1